1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALIGOS THERAPEUTICS INC
Aligos Therapeutics Inc
XNAS: ALGS
7.57 0.16 (2.16%)
40,321
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Aligos Therapeutics Inc - ALGS - stock price prediction, stock price target, analyst ratings from 5 analysts

Aligos Therapeutics Inc has a share price target of US$ 68, revenue growth forecast of -38.0%, and profit growth estimate of 65.5% for FY25, based on top 5 analyst calls.